World-renowned Alzheimer’s researcher and UNLV professor Jeffrey Cummings’ highly regarded 2024 annual report was featured in a journal of the Alzheimer’s Association. As the co-director of the Alzheimer’s drug development observatory within UNLV’s Department of Brain Health — the only observatory of its kind in the world —  Cummings' data for the annual Alzheimer’s drug development pipeline report keeps policy makers, healthcare systems, and patients apprised of the updates taking place among Alzheimer’s clinical trials.